Internship

Technology Rotational Development Program Internship

Confirmed live in the last 24 hours

Bristol-Myers Squibb

Bristol-Myers Squibb

10,001+ employees

Develops and delivers biopharmaceutical medicines

Biotechnology
Healthcare

No H1B Sponsorship

Princeton, NJ, USA

Onsite presence is essential for collaboration, innovation, productivity, and company culture.

Category
Data Management
Data Analysis
Data & Analytics
Requirements
  • Master of Business Administration (MBA), Master of Information Systems, or relevant Master program with graduation scheduled for Spring/Summer 2026
  • Minimum of 3 years of relevant digital, technology, or other relevant industry experience
  • Legally authorized to work in the United States on a full-time basis without the need for sponsorship for an employment visa now or in the future
Responsibilities
  • Learn and obtain expertise in technical and non-technical domains
  • Build a network throughout the IT organization, including exposure and mentorship with senior IT leaders and current members from the Technology Rotational Development Program (IT RDP)
  • Participate in events on key biopharma business and technology topics with senior leaders
  • Attend Team building and networking events across the company and with interns from across various functions
Desired Qualifications
  • Understanding of how to examine, assess, and provide innovative solutions to business issues
  • Ability to draw conclusions from complex situations, then recommend and execute a course of action in a timely manner
  • Demonstrated leadership experience through any of the following: professional work, student organizations, professional organizations, and community involvement
  • Excellent written and verbal communication skills with the ability to organize and present ideas in a convincing and compelling manner to small or large audiences at multiple levels within the organization

Bristol Myers Squibb (BMS) develops and delivers medicines aimed at treating serious diseases, focusing on areas like cancer, autoimmune diseases, and heart conditions. The company conducts extensive research and development to create new drugs, which are sold after receiving regulatory approval. BMS also produces generic drugs, offering affordable alternatives that meet the same quality standards as their branded counterparts. What sets BMS apart from competitors is its dual focus on both innovative and generic medicines, enhancing access to healthcare. The company's goal is to improve patient outcomes while maintaining a commitment to sustainability and corporate responsibility.

Company Stage

IPO

Total Funding

$33.7B

Headquarters

New York City, New York

Founded

1887

Simplify Jobs

Simplify's Take

What believers are saying

  • BMS's partnership with Medidata enhances digital trial management and patient engagement.
  • Collaboration with ArsenalBio advances T cell therapies, expanding BMS's oncology portfolio.
  • BMS Foundation's initiative in Sub-Saharan Africa boosts reputation in emerging markets.

What critics are saying

  • Increased competition in oncology from companies like ArsenalBio could impact BMS's market share.
  • Legal challenges, such as the lawsuit over the 340B Program, pose regulatory risks.
  • Reliance on external digital solutions like Medidata could be risky if partnerships falter.

What makes Bristol-Myers Squibb unique

  • BMS focuses on oncology, immunology, and cardiovascular diseases, setting it apart in biopharma.
  • The company invests heavily in R&D to develop innovative and generic medicines.
  • BMS emphasizes sustainability and ESG goals, enhancing its corporate responsibility image.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Flexible Work Hours

Hybrid Work Options

Professional Development Budget